Paul Baas

1 ta ish

The Netherlands Cancer Institute

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

   Julie R. Brahmer, Karen L. Reckamp, Paul Baas +22

   MaqolaOAOchiq kirish20153 iqtibos

   ABIABI:AkademIndex/2026.other.170111